Haemonetics rises on deal to acquire medical device maker Attune Medical

Haemonetics

05/03/2024 17:50

** Shares of healthcare company Haemonetics  HAE.N  rise
1.8% to $76.13 
    ** Co announces definitive agreement to acquire
privately-held medical device maker Attune Medical 
    ** As part of the deal, HAE to gain access to Attune's 
esophageal cooling device, ensoETM, which helps reduce
esophageal injury during surgical procedures
    ** Under the deal, co to make an upfront cash payment of
$160 mln as well as future milestone payments to Attune 
     ** Transaction is expected to be complete in Q1 of fiscal
2025 - HAE
    ** Including session moves, stock has fallen 1.8% in the
last 12 months  

 (Reporting by Sneha S K in Bengaluru)
 ((Sneha.SK@thomsonreuters.com;))